Service decision and evidence guide

GUDID portfolio preparation: identifiers, package hierarchy and submission ownership

The acquired GUDID guidance distinguishes the primary device identifier, package identifiers and production-identifier flags. It also separates account roles from web-interface or HL7 SPL submission. Map those relationships and ownership before choosing a tool; a public UDI listing is not regulatory approval.

Evidence retrieved 2026-10-06. Source versions and topic-specific limits are listed below.

Sourced criteria · US

What changes the service scope?

Decision or taskWhat the source describesWhat to prepare
Who owns the account and data quality?The guidance describes regulatory-contact, coordinator/entry and third-party submission roles, with labeler account responsibilities. [1]Assign authoritative field owners, approval/access roles and third-party responsibilities; keep private account contact details out of public requirements.
Web entry or HL7 SPL transmission?The guidance describes a labeler account supporting web-interface and HL7 SPL submission choices. [2]Compare actual portfolio/change volume, validation, response handling and support; verify current transmission specifications separately.
Which facts belong to the DI record?The guidance distinguishes device identifiers from production identifiers; production-identifier attributes are represented by flags rather than individual serial/lot values. [3]Map model/version identity and flags; do not import confidential batch/serial production data as public DI facts.
How do packages relate to the base device?The guidance describes primary/base and package identifiers for different package configurations, with quantities and relationships. [4]Prepare a package hierarchy and change log before migration; group package variants in buyer comparisons rather than creating a page per DI.

The acquired guidance is dated; current required/conditional fields, exceptions, XML/HL7 schemas, update status and account onboarding must be verified for the actual portfolio. This is not approval or a complete validated upload.

A scoped evidence and handoff plan

Use this checklist to gather your business or product details before speaking with a specialist. The items below explain what to record and suggest useful supporting documents. You can add your own answers in the editable project brief.

  1. Who owns the account and data quality?

    Assign authoritative field owners, approval/access roles and third-party responsibilities; keep private account contact details out of public requirements.

    Useful evidence: Role/approval matrix, labeler identity and data-quality responsibilities without credentials.

  2. Web entry or HL7 SPL transmission?

    Compare actual portfolio/change volume, validation, response handling and support; verify current transmission specifications separately.

    Useful evidence: Portfolio/change counts, system readiness and current method/version register.

  3. Which facts belong to the DI record?

    Map model/version identity and flags; do not import confidential batch/serial production data as public DI facts.

    Useful evidence: Model/version identity, issuer/DI evidence and documented production-identifier flags.

  4. How do packages relate to the base device?

    Prepare a package hierarchy and change log before migration; group package variants in buyer comparisons rather than creating a page per DI.

    Useful evidence: Base/package DI hierarchy, quantities, configurations and ownership/change checks.

Work packages and dependencies

Questions for providers

Sources and data dates

Read the official document in context. The audit details identify the precise locators and preserved versions used for this page.

US Food and Drug Administration — published reference ↗

Tue, 17 Dec 2024 13:41:17 GMT · retrieved 2026-10-06

Audit details: precise locators and snapshot identifiers

Source key D02 · snapshot 9b46b39b59d5267728273fa07f022e3db1d3b29b1d367fb8d67c82d6dc5f2669

  • [1] PDF page 10 · record 46670da030ec497f1471040c7dd201e886affad69451154aedc4e0e21a004d2a
  • [2] PDF page 11 · record fd3237d61d04329499dbee9ab45b4657e0216dfa1b9946c58f5e26d3c94bea88
  • [3] PDF page 13 · record 13c54a9360f8d5ea151e2ed112d02397cb33e441c918b6d0a9490987e22a1e92
  • [4] PDF page 15 · record f3f192c1339fee149ab5d7e746e1f073aeeb63f2b2efc6e648bb04403f250c83

Prepare an editable project brief

Confirm the facts, scope and contact preference before sharing your project. Preparing this page sends no provider outreach.

Choose work packages to discuss

Compare FDA GUDID Submission Tools